The Supreme Court unanimously rejects Nestle's (NSRGY.PK) Prometheus Labs request for two...

|About: Nestle S.A. ADR (NSRGY)|By:, SA News Editor

The Supreme Court unanimously rejects Nestle's (NSRGY.PK) Prometheus Labs request for two patents for a test that enables doctors to set drug dosages for patients with Crohn's disease. The justices explained that the IP was invalid, as it makes claims on laws of nature, which can't be patented.